Literature DB >> 27670390

Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation.

Catherine M Cahill1, Wendy Walwyn2, Anna M W Taylor2, Amynah A A Pradhan3, Christopher J Evans4.   

Abstract

Mechanisms of opioid tolerance have focused on adaptive modifications within cells containing opioid receptors, defined here as cellular allostasis, emphasizing regulation of the opioid receptor signalosome. We review additional regulatory and opponent processes involved in behavioral tolerance, and include mechanistic differences both between agonists (agonist bias), and between μ- and δ-opioid receptors. In a process we will refer to as pass-forward allostasis, cells modified directly by opioid drugs impute allostatic changes to downstream circuitry. Because of the broad distribution of opioid systems, every brain cell may be touched by pass-forward allostasis in the opioid-dependent/tolerant state. We will implicate neurons and microglia as interactive contributors to the cumulative allostatic processes creating analgesic and hedonic tolerance to opioid drugs.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  arrestin; bias signaling; dopamine; microglia; opponent processes; reward; μ opioid receptor

Mesh:

Substances:

Year:  2016        PMID: 27670390      PMCID: PMC5240843          DOI: 10.1016/j.tips.2016.08.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  128 in total

1.  Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness "liking" and "wanting".

Authors:  Daniel C Castro; Kent C Berridge
Journal:  J Neurosci       Date:  2014-03-19       Impact factor: 6.167

2.  Heroin "overdose" death: contribution of drug-associated environmental cues.

Authors:  S Siegel; R E Hinson; M D Krank; J McCully
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

Review 3.  Role of Dopamine Neurons in Reward and Aversion: A Synaptic Plasticity Perspective.

Authors:  Marco Pignatelli; Antonello Bonci
Journal:  Neuron       Date:  2015-06-03       Impact factor: 17.173

4.  Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats.

Authors:  Terry E Robinson; Grazyna Gorny; Virginia R Savage; Bryan Kolb
Journal:  Synapse       Date:  2002-12-15       Impact factor: 2.562

5.  Acquisition of morphine conditioned place preference increases the dendritic complexity of nucleus accumbens core neurons.

Authors:  Kendra L Kobrin; Olivia Moody; Danielle T Arena; Catherine F Moore; Stephen C Heinrichs; Gary B Kaplan
Journal:  Addict Biol       Date:  2015-06-19       Impact factor: 4.280

6.  Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal.

Authors:  Francesco Papaleo; Pierre Kitchener; Angelo Contarino
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

7.  Evidence that behavioral phenotypes of morphine in β-arr2-/- mice are due to the unmasking of JNK signaling.

Authors:  Nitish Mittal; Miao Tan; Onyemachi Egbuta; Nina Desai; Cynthia Crawford; Cui-Wei Xie; Christopher Evans; Wendy Walwyn
Journal:  Neuropsychopharmacology       Date:  2012-04-11       Impact factor: 7.853

8.  Morphine side effects in beta-arrestin 2 knockout mice.

Authors:  Kirsten M Raehal; Julia K L Walker; Laura M Bohn
Journal:  J Pharmacol Exp Ther       Date:  2005-05-25       Impact factor: 4.030

9.  Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity.

Authors:  Ashlee Van't Veer; Anita J Bechtholt; Sara Onvani; David Potter; Yujun Wang; Lee-Yuan Liu-Chen; Günther Schütz; Elena H Chartoff; Uwe Rudolph; Bruce M Cohen; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2013-02-27       Impact factor: 7.853

10.  A novel role of spinal astrocytic connexin 43: mediating morphine antinociceptive tolerance by activation of NMDA receptors and inhibition of glutamate transporter-1 in rats.

Authors:  Ning Shen; Li-Qiu Mo; Fen Hu; Pei-Xi Chen; Rui-Xian Guo; Jian-Qiang Feng
Journal:  CNS Neurosci Ther       Date:  2014-03-15       Impact factor: 5.243

View more
  38 in total

Review 1.  Non-nociceptive roles of opioids in the CNS: opioids' effects on neurogenesis, learning, memory and affect.

Authors:  Cherkaouia Kibaly; Chi Xu; Catherine M Cahill; Christopher J Evans; Ping-Yee Law
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

2.  Quantifying enhanced risk from alcohol and other factors in polysubstance-related deaths.

Authors:  Zheng Dai; Marie A Abate; D Leann Long; Gordon S Smith; Theresa M Halki; James C Kraner; Allen R Mock
Journal:  Forensic Sci Int       Date:  2020-05-31       Impact factor: 2.395

Review 3.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 4.  Opioid Tolerance in Critical Illness.

Authors:  J A Jeevendra Martyn; Jianren Mao; Edward A Bittner
Journal:  N Engl J Med       Date:  2019-01-24       Impact factor: 91.245

5.  A Practical Approach to Acute Postoperative Pain Management in Chronic Pain Patients.

Authors:  Edwin N Aroke; Susan P McMullan; Katie O Woodfin; Ryan Richey; Jordan Doss; Bryan A Wilbanks
Journal:  J Perianesth Nurs       Date:  2020-07-11       Impact factor: 1.084

6.  Opioid-Induced Tolerance and Hyperalgesia.

Authors:  Sebastiano Mercadante; Edoardo Arcuri; Angela Santoni
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

7.  Opioids: keeping the good, eliminating the bad.

Authors:  Stephanie Puig; Howard B Gutstein
Journal:  Nat Med       Date:  2017-01-30       Impact factor: 53.440

8.  Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization.

Authors:  S Puig; K E Barker; S R Szott; P T Kann; J S Morris; H B Gutstein
Journal:  Mol Pharmacol       Date:  2020-07-28       Impact factor: 4.436

9.  Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Authors:  Sevasti Gaspari; Immanuel Purushothaman; Valeria Cogliani; Farhana Sakloth; Rachael L Neve; David Howland; Robert H Ring; Elliott M Ross; Li Shen; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

10.  History of opioid use as a risk factor for current use and mental health consequences among retired National Football League athletes: A 9-year follow-up investigation.

Authors:  Zachary L Mannes; Eugene M Dunne; Erin G Ferguson; Linda B Cottler; Nicole Ennis
Journal:  Drug Alcohol Depend       Date:  2020-08-28       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.